Global Chinese Medicine Reference Substance (CMRS) Market Growth 2025-2031

Product Code: 1704440

Industry: Pharma & Healthcare

Published: Jul 11,2025

Pages: 118

Delivery Time: 2-3 business days

Global Chinese Medicine Reference Substance (CMRS) Market Growth 2025-2031

Product Code: 1704440

Industry: Pharma & Healthcare

Published: Jul 11,2025

Pages: 118

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Chinese Medicine Reference Substance (CMRS) market size is predicted to grow from US$ 1806 million in 2025 to US$ 2798 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

A Chinese Medicine Reference Substance (CMRS) is a standardized, pure compound or extract derived from a Traditional Chinese Medicine (TCM) herb or formula. It serves as a benchmark in quality control, authentication, and pharmacological research.

United States market for Chinese Medicine Reference Substance (CMRS) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Chinese Medicine Reference Substance (CMRS) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Chinese Medicine Reference Substance (CMRS) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Chinese Medicine Reference Substance (CMRS) players cover Desite, ChemFaces, GeLiPuBio, ChromaDex, Chengdu Must Biotechnology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Chinese Medicine Reference Substance (CMRS) Industry Forecast” looks at past sales and reviews total world Chinese Medicine Reference Substance (CMRS) sales in 2024, providing a comprehensive analysis by region and market sector of projected Chinese Medicine Reference Substance (CMRS) sales for 2025 through 2031. With Chinese Medicine Reference Substance (CMRS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chinese Medicine Reference Substance (CMRS) industry.

This Insight Report provides a comprehensive analysis of the global Chinese Medicine Reference Substance (CMRS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chinese Medicine Reference Substance (CMRS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chinese Medicine Reference Substance (CMRS) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chinese Medicine Reference Substance (CMRS) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chinese Medicine Reference Substance (CMRS).

This report presents a comprehensive overview, market shares, and growth opportunities of Chinese Medicine Reference Substance (CMRS) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Plant-Derived Reference Substances
    Animal-Derived Reference Substances
    Mineral-Derived Reference Substances
    Chemically Synthesized Reference Substances

Segmentation by Application:
    Pharmaceutical Identification
    Pharmaceutical Development

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Desite
    ChemFaces
    GeLiPuBio
    ChromaDex
    Chengdu Must Biotechnology
    Derick
    RENI Pharmaceutical Technology
    Purechemland
    Nature Standard
    Diagnocine
    Baoji Herbest Bio-Tech
    PhytoLab

Key Questions Addressed in this Report
What is the 10-year outlook for the global Chinese Medicine Reference Substance (CMRS) market?
What factors are driving Chinese Medicine Reference Substance (CMRS) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chinese Medicine Reference Substance (CMRS) market opportunities vary by end market size?
How does Chinese Medicine Reference Substance (CMRS) break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Chinese Medicine Reference Substance (CMRS) Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Chinese Medicine Reference Substance (CMRS) by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Chinese Medicine Reference Substance (CMRS) by Country/Region, 2020, 2024 & 2031
    2.2 Chinese Medicine Reference Substance (CMRS) Segment by Type
        2.2.1 Plant-Derived Reference Substances
        2.2.2 Animal-Derived Reference Substances
        2.2.3 Mineral-Derived Reference Substances
        2.2.4 Chemically Synthesized Reference Substances
    2.3 Chinese Medicine Reference Substance (CMRS) Sales by Type
        2.3.1 Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2020-2025)
        2.3.2 Global Chinese Medicine Reference Substance (CMRS) Revenue and Market Share by Type (2020-2025)
        2.3.3 Global Chinese Medicine Reference Substance (CMRS) Sale Price by Type (2020-2025)
    2.4 Chinese Medicine Reference Substance (CMRS) Segment by Application
        2.4.1 Pharmaceutical Identification
        2.4.2 Pharmaceutical Development
    2.5 Chinese Medicine Reference Substance (CMRS) Sales by Application
        2.5.1 Global Chinese Medicine Reference Substance (CMRS) Sale Market Share by Application (2020-2025)
        2.5.2 Global Chinese Medicine Reference Substance (CMRS) Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Chinese Medicine Reference Substance (CMRS) Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Chinese Medicine Reference Substance (CMRS) Breakdown Data by Company
        3.1.1 Global Chinese Medicine Reference Substance (CMRS) Annual Sales by Company (2020-2025)
        3.1.2 Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Company (2020-2025)
    3.2 Global Chinese Medicine Reference Substance (CMRS) Annual Revenue by Company (2020-2025)
        3.2.1 Global Chinese Medicine Reference Substance (CMRS) Revenue by Company (2020-2025)
        3.2.2 Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Company (2020-2025)
    3.3 Global Chinese Medicine Reference Substance (CMRS) Sale Price by Company
    3.4 Key Manufacturers Chinese Medicine Reference Substance (CMRS) Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Chinese Medicine Reference Substance (CMRS) Product Location Distribution
        3.4.2 Players Chinese Medicine Reference Substance (CMRS) Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Chinese Medicine Reference Substance (CMRS) by Geographic Region
    4.1 World Historic Chinese Medicine Reference Substance (CMRS) Market Size by Geographic Region (2020-2025)
        4.1.1 Global Chinese Medicine Reference Substance (CMRS) Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Chinese Medicine Reference Substance (CMRS) Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Chinese Medicine Reference Substance (CMRS) Market Size by Country/Region (2020-2025)
        4.2.1 Global Chinese Medicine Reference Substance (CMRS) Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Chinese Medicine Reference Substance (CMRS) Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Chinese Medicine Reference Substance (CMRS) Sales Growth
    4.4 APAC Chinese Medicine Reference Substance (CMRS) Sales Growth
    4.5 Europe Chinese Medicine Reference Substance (CMRS) Sales Growth
    4.6 Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales Growth

5 Americas
    5.1 Americas Chinese Medicine Reference Substance (CMRS) Sales by Country
        5.1.1 Americas Chinese Medicine Reference Substance (CMRS) Sales by Country (2020-2025)
        5.1.2 Americas Chinese Medicine Reference Substance (CMRS) Revenue by Country (2020-2025)
    5.2 Americas Chinese Medicine Reference Substance (CMRS) Sales by Type (2020-2025)
    5.3 Americas Chinese Medicine Reference Substance (CMRS) Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Chinese Medicine Reference Substance (CMRS) Sales by Region
        6.1.1 APAC Chinese Medicine Reference Substance (CMRS) Sales by Region (2020-2025)
        6.1.2 APAC Chinese Medicine Reference Substance (CMRS) Revenue by Region (2020-2025)
    6.2 APAC Chinese Medicine Reference Substance (CMRS) Sales by Type (2020-2025)
    6.3 APAC Chinese Medicine Reference Substance (CMRS) Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Chinese Medicine Reference Substance (CMRS) by Country
        7.1.1 Europe Chinese Medicine Reference Substance (CMRS) Sales by Country (2020-2025)
        7.1.2 Europe Chinese Medicine Reference Substance (CMRS) Revenue by Country (2020-2025)
    7.2 Europe Chinese Medicine Reference Substance (CMRS) Sales by Type (2020-2025)
    7.3 Europe Chinese Medicine Reference Substance (CMRS) Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Chinese Medicine Reference Substance (CMRS) by Country
        8.1.1 Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Chinese Medicine Reference Substance (CMRS) Revenue by Country (2020-2025)
    8.2 Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales by Type (2020-2025)
    8.3 Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Chinese Medicine Reference Substance (CMRS)
    10.3 Manufacturing Process Analysis of Chinese Medicine Reference Substance (CMRS)
    10.4 Industry Chain Structure of Chinese Medicine Reference Substance (CMRS)

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Chinese Medicine Reference Substance (CMRS) Distributors
    11.3 Chinese Medicine Reference Substance (CMRS) Customer

12 World Forecast Review for Chinese Medicine Reference Substance (CMRS) by Geographic Region
    12.1 Global Chinese Medicine Reference Substance (CMRS) Market Size Forecast by Region
        12.1.1 Global Chinese Medicine Reference Substance (CMRS) Forecast by Region (2026-2031)
        12.1.2 Global Chinese Medicine Reference Substance (CMRS) Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Chinese Medicine Reference Substance (CMRS) Forecast by Type (2026-2031)
    12.7 Global Chinese Medicine Reference Substance (CMRS) Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Desite
        13.1.1 Desite Company Information
        13.1.2 Desite Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.1.3 Desite Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Desite Main Business Overview
        13.1.5 Desite Latest Developments
    13.2 ChemFaces
        13.2.1 ChemFaces Company Information
        13.2.2 ChemFaces Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.2.3 ChemFaces Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 ChemFaces Main Business Overview
        13.2.5 ChemFaces Latest Developments
    13.3 GeLiPuBio
        13.3.1 GeLiPuBio Company Information
        13.3.2 GeLiPuBio Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.3.3 GeLiPuBio Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 GeLiPuBio Main Business Overview
        13.3.5 GeLiPuBio Latest Developments
    13.4 ChromaDex
        13.4.1 ChromaDex Company Information
        13.4.2 ChromaDex Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.4.3 ChromaDex Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 ChromaDex Main Business Overview
        13.4.5 ChromaDex Latest Developments
    13.5 Chengdu Must Biotechnology
        13.5.1 Chengdu Must Biotechnology Company Information
        13.5.2 Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.5.3 Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Chengdu Must Biotechnology Main Business Overview
        13.5.5 Chengdu Must Biotechnology Latest Developments
    13.6 Derick
        13.6.1 Derick Company Information
        13.6.2 Derick Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.6.3 Derick Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Derick Main Business Overview
        13.6.5 Derick Latest Developments
    13.7 RENI Pharmaceutical Technology
        13.7.1 RENI Pharmaceutical Technology Company Information
        13.7.2 RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.7.3 RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 RENI Pharmaceutical Technology Main Business Overview
        13.7.5 RENI Pharmaceutical Technology Latest Developments
    13.8 Purechemland
        13.8.1 Purechemland Company Information
        13.8.2 Purechemland Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.8.3 Purechemland Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Purechemland Main Business Overview
        13.8.5 Purechemland Latest Developments
    13.9 Nature Standard
        13.9.1 Nature Standard Company Information
        13.9.2 Nature Standard Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.9.3 Nature Standard Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 Nature Standard Main Business Overview
        13.9.5 Nature Standard Latest Developments
    13.10 Diagnocine
        13.10.1 Diagnocine Company Information
        13.10.2 Diagnocine Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.10.3 Diagnocine Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 Diagnocine Main Business Overview
        13.10.5 Diagnocine Latest Developments
    13.11 Baoji Herbest Bio-Tech
        13.11.1 Baoji Herbest Bio-Tech Company Information
        13.11.2 Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.11.3 Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.11.4 Baoji Herbest Bio-Tech Main Business Overview
        13.11.5 Baoji Herbest Bio-Tech Latest Developments
    13.12 PhytoLab
        13.12.1 PhytoLab Company Information
        13.12.2 PhytoLab Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
        13.12.3 PhytoLab Chinese Medicine Reference Substance (CMRS) Sales, Revenue, Price and Gross Margin (2020-2025)
        13.12.4 PhytoLab Main Business Overview
        13.12.5 PhytoLab Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Chinese Medicine Reference Substance (CMRS) Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Chinese Medicine Reference Substance (CMRS) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Plant-Derived Reference Substances
 Table 4. Major Players of Animal-Derived Reference Substances
 Table 5. Major Players of Mineral-Derived Reference Substances
 Table 6. Major Players of Chemically Synthesized Reference Substances
 Table 7. Global Chinese Medicine Reference Substance (CMRS) Sales by Type (2020-2025) & (K Units)
 Table 8. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2020-2025)
 Table 9. Global Chinese Medicine Reference Substance (CMRS) Revenue by Type (2020-2025) & ($ million)
 Table 10. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Type (2020-2025)
 Table 11. Global Chinese Medicine Reference Substance (CMRS) Sale Price by Type (2020-2025) & (US$/Unit)
 Table 12. Global Chinese Medicine Reference Substance (CMRS) Sale by Application (2020-2025) & (K Units)
 Table 13. Global Chinese Medicine Reference Substance (CMRS) Sale Market Share by Application (2020-2025)
 Table 14. Global Chinese Medicine Reference Substance (CMRS) Revenue by Application (2020-2025) & ($ million)
 Table 15. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Application (2020-2025)
 Table 16. Global Chinese Medicine Reference Substance (CMRS) Sale Price by Application (2020-2025) & (US$/Unit)
 Table 17. Global Chinese Medicine Reference Substance (CMRS) Sales by Company (2020-2025) & (K Units)
 Table 18. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Company (2020-2025)
 Table 19. Global Chinese Medicine Reference Substance (CMRS) Revenue by Company (2020-2025) & ($ millions)
 Table 20. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Company (2020-2025)
 Table 21. Global Chinese Medicine Reference Substance (CMRS) Sale Price by Company (2020-2025) & (US$/Unit)
 Table 22. Key Manufacturers Chinese Medicine Reference Substance (CMRS) Producing Area Distribution and Sales Area
 Table 23. Players Chinese Medicine Reference Substance (CMRS) Products Offered
 Table 24. Chinese Medicine Reference Substance (CMRS) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 25. New Products and Potential Entrants
 Table 26. Market M&A Activity & Strategy
 Table 27. Global Chinese Medicine Reference Substance (CMRS) Sales by Geographic Region (2020-2025) & (K Units)
 Table 28. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share Geographic Region (2020-2025)
 Table 29. Global Chinese Medicine Reference Substance (CMRS) Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 30. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Geographic Region (2020-2025)
 Table 31. Global Chinese Medicine Reference Substance (CMRS) Sales by Country/Region (2020-2025) & (K Units)
 Table 32. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country/Region (2020-2025)
 Table 33. Global Chinese Medicine Reference Substance (CMRS) Revenue by Country/Region (2020-2025) & ($ millions)
 Table 34. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Country/Region (2020-2025)
 Table 35. Americas Chinese Medicine Reference Substance (CMRS) Sales by Country (2020-2025) & (K Units)
 Table 36. Americas Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2020-2025)
 Table 37. Americas Chinese Medicine Reference Substance (CMRS) Revenue by Country (2020-2025) & ($ millions)
 Table 38. Americas Chinese Medicine Reference Substance (CMRS) Sales by Type (2020-2025) & (K Units)
 Table 39. Americas Chinese Medicine Reference Substance (CMRS) Sales by Application (2020-2025) & (K Units)
 Table 40. APAC Chinese Medicine Reference Substance (CMRS) Sales by Region (2020-2025) & (K Units)
 Table 41. APAC Chinese Medicine Reference Substance (CMRS) Sales Market Share by Region (2020-2025)
 Table 42. APAC Chinese Medicine Reference Substance (CMRS) Revenue by Region (2020-2025) & ($ millions)
 Table 43. APAC Chinese Medicine Reference Substance (CMRS) Sales by Type (2020-2025) & (K Units)
 Table 44. APAC Chinese Medicine Reference Substance (CMRS) Sales by Application (2020-2025) & (K Units)
 Table 45. Europe Chinese Medicine Reference Substance (CMRS) Sales by Country (2020-2025) & (K Units)
 Table 46. Europe Chinese Medicine Reference Substance (CMRS) Revenue by Country (2020-2025) & ($ millions)
 Table 47. Europe Chinese Medicine Reference Substance (CMRS) Sales by Type (2020-2025) & (K Units)
 Table 48. Europe Chinese Medicine Reference Substance (CMRS) Sales by Application (2020-2025) & (K Units)
 Table 49. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales by Country (2020-2025) & (K Units)
 Table 50. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Country (2020-2025)
 Table 51. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales by Type (2020-2025) & (K Units)
 Table 52. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales by Application (2020-2025) & (K Units)
 Table 53. Key Market Drivers & Growth Opportunities of Chinese Medicine Reference Substance (CMRS)
 Table 54. Key Market Challenges & Risks of Chinese Medicine Reference Substance (CMRS)
 Table 55. Key Industry Trends of Chinese Medicine Reference Substance (CMRS)
 Table 56. Chinese Medicine Reference Substance (CMRS) Raw Material
 Table 57. Key Suppliers of Raw Materials
 Table 58. Chinese Medicine Reference Substance (CMRS) Distributors List
 Table 59. Chinese Medicine Reference Substance (CMRS) Customer List
 Table 60. Global Chinese Medicine Reference Substance (CMRS) Sales Forecast by Region (2026-2031) & (K Units)
 Table 61. Global Chinese Medicine Reference Substance (CMRS) Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 62. Americas Chinese Medicine Reference Substance (CMRS) Sales Forecast by Country (2026-2031) & (K Units)
 Table 63. Americas Chinese Medicine Reference Substance (CMRS) Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 64. APAC Chinese Medicine Reference Substance (CMRS) Sales Forecast by Region (2026-2031) & (K Units)
 Table 65. APAC Chinese Medicine Reference Substance (CMRS) Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 66. Europe Chinese Medicine Reference Substance (CMRS) Sales Forecast by Country (2026-2031) & (K Units)
 Table 67. Europe Chinese Medicine Reference Substance (CMRS) Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales Forecast by Country (2026-2031) & (K Units)
 Table 69. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 70. Global Chinese Medicine Reference Substance (CMRS) Sales Forecast by Type (2026-2031) & (K Units)
 Table 71. Global Chinese Medicine Reference Substance (CMRS) Revenue Forecast by Type (2026-2031) & ($ millions)
 Table 72. Global Chinese Medicine Reference Substance (CMRS) Sales Forecast by Application (2026-2031) & (K Units)
 Table 73. Global Chinese Medicine Reference Substance (CMRS) Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 74. Desite Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 75. Desite Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 76. Desite Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 77. Desite Main Business
 Table 78. Desite Latest Developments
 Table 79. ChemFaces Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 80. ChemFaces Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 81. ChemFaces Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 82. ChemFaces Main Business
 Table 83. ChemFaces Latest Developments
 Table 84. GeLiPuBio Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 85. GeLiPuBio Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 86. GeLiPuBio Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 87. GeLiPuBio Main Business
 Table 88. GeLiPuBio Latest Developments
 Table 89. ChromaDex Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 90. ChromaDex Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 91. ChromaDex Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 92. ChromaDex Main Business
 Table 93. ChromaDex Latest Developments
 Table 94. Chengdu Must Biotechnology Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 95. Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 96. Chengdu Must Biotechnology Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 97. Chengdu Must Biotechnology Main Business
 Table 98. Chengdu Must Biotechnology Latest Developments
 Table 99. Derick Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 100. Derick Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 101. Derick Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 102. Derick Main Business
 Table 103. Derick Latest Developments
 Table 104. RENI Pharmaceutical Technology Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 105. RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 106. RENI Pharmaceutical Technology Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 107. RENI Pharmaceutical Technology Main Business
 Table 108. RENI Pharmaceutical Technology Latest Developments
 Table 109. Purechemland Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 110. Purechemland Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 111. Purechemland Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 112. Purechemland Main Business
 Table 113. Purechemland Latest Developments
 Table 114. Nature Standard Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 115. Nature Standard Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 116. Nature Standard Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 117. Nature Standard Main Business
 Table 118. Nature Standard Latest Developments
 Table 119. Diagnocine Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 120. Diagnocine Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 121. Diagnocine Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 122. Diagnocine Main Business
 Table 123. Diagnocine Latest Developments
 Table 124. Baoji Herbest Bio-Tech Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 125. Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 126. Baoji Herbest Bio-Tech Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 127. Baoji Herbest Bio-Tech Main Business
 Table 128. Baoji Herbest Bio-Tech Latest Developments
 Table 129. PhytoLab Basic Information, Chinese Medicine Reference Substance (CMRS) Manufacturing Base, Sales Area and Its Competitors
 Table 130. PhytoLab Chinese Medicine Reference Substance (CMRS) Product Portfolios and Specifications
 Table 131. PhytoLab Chinese Medicine Reference Substance (CMRS) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 132. PhytoLab Main Business
 Table 133. PhytoLab Latest Developments


List of Figures
 Figure 1. Picture of Chinese Medicine Reference Substance (CMRS)
 Figure 2. Chinese Medicine Reference Substance (CMRS) Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Chinese Medicine Reference Substance (CMRS) Sales Growth Rate 2020-2031 (K Units)
 Figure 7. Global Chinese Medicine Reference Substance (CMRS) Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Chinese Medicine Reference Substance (CMRS) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country/Region (2024)
 Figure 10. Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Plant-Derived Reference Substances
 Figure 12. Product Picture of Animal-Derived Reference Substances
 Figure 13. Product Picture of Mineral-Derived Reference Substances
 Figure 14. Product Picture of Chemically Synthesized Reference Substances
 Figure 15. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type in 2025
 Figure 16. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Type (2020-2025)
 Figure 17. Chinese Medicine Reference Substance (CMRS) Consumed in Pharmaceutical Identification
 Figure 18. Global Chinese Medicine Reference Substance (CMRS) Market: Pharmaceutical Identification (2020-2025) & (K Units)
 Figure 19. Chinese Medicine Reference Substance (CMRS) Consumed in Pharmaceutical Development
 Figure 20. Global Chinese Medicine Reference Substance (CMRS) Market: Pharmaceutical Development (2020-2025) & (K Units)
 Figure 21. Global Chinese Medicine Reference Substance (CMRS) Sale Market Share by Application (2024)
 Figure 22. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Application in 2025
 Figure 23. Chinese Medicine Reference Substance (CMRS) Sales by Company in 2025 (K Units)
 Figure 24. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Company in 2025
 Figure 25. Chinese Medicine Reference Substance (CMRS) Revenue by Company in 2025 ($ millions)
 Figure 26. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Company in 2025
 Figure 27. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share by Geographic Region (2020-2025)
 Figure 28. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Geographic Region in 2025
 Figure 29. Americas Chinese Medicine Reference Substance (CMRS) Sales 2020-2025 (K Units)
 Figure 30. Americas Chinese Medicine Reference Substance (CMRS) Revenue 2020-2025 ($ millions)
 Figure 31. APAC Chinese Medicine Reference Substance (CMRS) Sales 2020-2025 (K Units)
 Figure 32. APAC Chinese Medicine Reference Substance (CMRS) Revenue 2020-2025 ($ millions)
 Figure 33. Europe Chinese Medicine Reference Substance (CMRS) Sales 2020-2025 (K Units)
 Figure 34. Europe Chinese Medicine Reference Substance (CMRS) Revenue 2020-2025 ($ millions)
 Figure 35. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales 2020-2025 (K Units)
 Figure 36. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Revenue 2020-2025 ($ millions)
 Figure 37. Americas Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country in 2025
 Figure 38. Americas Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Country (2020-2025)
 Figure 39. Americas Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2020-2025)
 Figure 40. Americas Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2020-2025)
 Figure 41. United States Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 42. Canada Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 43. Mexico Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 44. Brazil Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 45. APAC Chinese Medicine Reference Substance (CMRS) Sales Market Share by Region in 2025
 Figure 46. APAC Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Region (2020-2025)
 Figure 47. APAC Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2020-2025)
 Figure 48. APAC Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2020-2025)
 Figure 49. China Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 50. Japan Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 51. South Korea Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 52. Southeast Asia Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 53. India Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 54. Australia Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 55. China Taiwan Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 56. Europe Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country in 2025
 Figure 57. Europe Chinese Medicine Reference Substance (CMRS) Revenue Market Share by Country (2020-2025)
 Figure 58. Europe Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2020-2025)
 Figure 59. Europe Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2020-2025)
 Figure 60. Germany Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 61. France Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 62. UK Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 63. Italy Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 64. Russia Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 65. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales Market Share by Country (2020-2025)
 Figure 66. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales Market Share by Type (2020-2025)
 Figure 67. Middle East & Africa Chinese Medicine Reference Substance (CMRS) Sales Market Share by Application (2020-2025)
 Figure 68. Egypt Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 69. South Africa Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 70. Israel Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 71. Turkey Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 72. GCC Countries Chinese Medicine Reference Substance (CMRS) Revenue Growth 2020-2025 ($ millions)
 Figure 73. Manufacturing Cost Structure Analysis of Chinese Medicine Reference Substance (CMRS) in 2025
 Figure 74. Manufacturing Process Analysis of Chinese Medicine Reference Substance (CMRS)
 Figure 75. Industry Chain Structure of Chinese Medicine Reference Substance (CMRS)
 Figure 76. Channels of Distribution
 Figure 77. Global Chinese Medicine Reference Substance (CMRS) Sales Market Forecast by Region (2026-2031)
 Figure 78. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share Forecast by Region (2026-2031)
 Figure 79. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share Forecast by Type (2026-2031)
 Figure 80. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share Forecast by Type (2026-2031)
 Figure 81. Global Chinese Medicine Reference Substance (CMRS) Sales Market Share Forecast by Application (2026-2031)
 Figure 82. Global Chinese Medicine Reference Substance (CMRS) Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Desite

ChemFaces

GeLiPuBio

ChromaDex

Chengdu Must Biotechnology

Derick

RENI Pharmaceutical Technology

Purechemland

Nature Standard

Diagnocine

Baoji Herbest Bio-Tech

PhytoLab

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff